BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.85% |
| 2 | Financials | 5.5% |
| 3 | Healthcare | 5.05% |
| 4 | Consumer Discretionary | 4.67% |
| 5 | Industrials | 3.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
NeoGenomics
NEO
$2.05B
| $807K | ﹤0.01% |
27,580
+10,426
| +61% | +$248K |
|
|
SRCL
2052
DELISTED
Stericycle Inc
SRCL
| $806K | ﹤0.01% |
12,637
-1,812
| -13% | -$107K |
|
2053
United Bankshares
UBSI
$6.69B
| $805K | ﹤0.01% |
20,830
+677
| +3% | +$26.1K |
|
2054
Webster Financial
WBS
$12.8B
| $803K | ﹤0.01% |
15,049
-7,414
| -33% | -$357K |
|
2055
CALL
United States Oil Fund
USO
$1.79B
| $801K | ﹤0.01% |
78
-250
| -76% | -$23.8K |
|
2056
Casey's General Stores
CASY
$31.6B
| $800K | ﹤0.01% |
5,033
-10,333
| -67% | -$1.71M |
|
|
GBT
2057
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $799K | ﹤0.01% |
10,056
-18,379
| -65% | -$1.09M |
|
2058
Power Integrations
POWI
$3.49B
| $799K | ﹤0.01% |
16,152
+5,730
| +55% | +$264K |
|
2059
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.48B
| $798K | ﹤0.01% |
19,811
+6,421
| +48% | +$256K |
|
|
CTLT
2060
DELISTED
CATALENT, INC.
CTLT
| $798K | ﹤0.01% |
14,170
-5,736
| -29% | -$292K |
|
2061
CALL
Campbell Soup
CPB
$6.92B
| $796K | ﹤0.01% |
+161
| New | +$7.63K |
|
2062
J&J Snack Foods
JJSF
$1.68B
| $793K | ﹤0.01% |
4,305
+1,538
| +56% | +$290K |
|
2063
Global X US Preferred ETF
PFFD
$2.17B
| $791K | ﹤0.01% |
31,594
+6,603
| +26% | +$165K |
|
|
PRA
2064
DELISTED
ProAssurance
PRA
| $790K | ﹤0.01% |
21,857
+9,986
| +84% | +$383K |
|
2065
Pegasystems
PEGA
$5.3B
| $789K | ﹤0.01% |
19,824
+1,930
| +11% | +$73K |
|
2066
Stepan Co
SCL
$1.48B
| $789K | ﹤0.01% |
7,702
+3,988
| +107% | +$389K |
|
2067
Coherent
COHR
$63.7B
| $789K | ﹤0.01% |
23,427
+12,097
| +107% | +$386K |
|
2068
Diamondrock Hospitality Co
DRH
$2.53B
| $788K | ﹤0.01% |
71,089
-167,254
| -70% | -$1.73M |
|
2069
OneSpan
OSPN
$602M
| $788K | ﹤0.01% |
46,006
+40,939
| +808% | +$696K |
|
|
JBGS
2070
JBG SMITH
JBGS
$677M
| $787K | ﹤0.01% |
19,737
-38,164
| -66% | -$1.51M |
|
|
CHK
2071
PUT
DELISTED
Chesapeake Energy Corporation
CHK
| $787K | ﹤0.01% |
48
-40
| -45% | -$8.04K |
|
2072
Guardant Health
GH
$21.2B
| $786K | ﹤0.01% |
10,055
+7,491
| +292% | +$540K |
|
|
TSG
2073
CALL
DELISTED
The Stars Group Inc.
TSG
| $783K | ﹤0.01% |
300
-800
| -73% | -$17.9K |
|
2074
FirstCash
FCFS
$9.22B
| $782K | ﹤0.01% |
9,703
+678
| +8% | +$57K |
|
|
LCI
2075
DELISTED
Lannett Company, Inc.
LCI
| $782K | ﹤0.01% |
22,163
+20,913
| +1,673% | +$850K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, down from 8.4% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.